Association of Chronic Medical Conditions With Severe Outcomes Among Nonpregnant Adults 18-49 Years Old Hospitalized With Influenza, FluSurv-NET, 2011-2019
- PMID: 38130595
- PMCID: PMC10733180
- DOI: 10.1093/ofid/ofad599
Association of Chronic Medical Conditions With Severe Outcomes Among Nonpregnant Adults 18-49 Years Old Hospitalized With Influenza, FluSurv-NET, 2011-2019
Abstract
Background: Older age and chronic conditions are associated with severe influenza outcomes; however, data are only comprehensively available for adults ≥65 years old. Using data from the Influenza Hospitalization Surveillance Network (FluSurv-NET), we identified characteristics associated with severe outcomes in adults 18-49 years old hospitalized with influenza.
Methods: We included FluSurv-NET data from nonpregnant adults 18-49 years old hospitalized with laboratory-confirmed influenza during the 2011-2012 through 2018-2019 seasons. We used bivariate and multivariable logistic regression to determine associations between select characteristics and severe outcomes including intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and in-hospital death.
Results: A total of 16 140 patients aged 18-49 years and hospitalized with influenza were included in the analysis; the median age was 39 years, and 26% received current-season influenza vaccine before hospitalization. Obesity, asthma, and diabetes mellitus were the most common chronic conditions. Conditions associated with a significantly increased risk of severe outcomes included age group 30-39 or 40-49 years (IMV, age group 30-39 years: adjusted odds ratio [aOR], 1.25; IMV, age group 40-49 years: aOR, 1.36; death, age group 30-39 years: aOR, 1.28; death, age group 40-49 years: aOR, 1.69), being unvaccinated (ICU: aOR, 1.18; IMV: aOR, 1.25; death: aOR, 1.48), and having chronic conditions including extreme obesity and chronic lung, cardiovascular, metabolic, neurologic, or liver diseases (ICU: range aOR, 1.22-1.56; IMV: range aOR, 1.17-1.54; death: range aOR, 1.43-2.36).
Conclusions: To reduce the morbidity and mortality associated with influenza among adults aged 18-49 years, health care providers should strongly encourage receipt of annual influenza vaccine and lifestyle/behavioral modifications, particularly among those with chronic medical conditions.
Keywords: adults; chronic conditions; hospitalizations; influenza; severe.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. D.U. reports that he is a contract employee of GDIT. K.Y.H. reports grants from the CDC for the Connecticut Emerging Infections Program. M.M. reports grants from the CDC for the Emerging Infections Program. P.R. reports funding support from the Emerging Infections Program Cooperative agreement. A.F. reports grants from the Michigan Department of Health and Human Services from the CSTE Federal Grand. S.K. reports grants from the Michigan Department of Health and Human Services from the CSTE Federal Grand. R.L. reports grants from the CDC Emerging Infections Cooperative Agreement to the MN Department of Health. S.K. reports salary and data collection for the manuscript supported by a grant received from the CDC Emerging Infections Program. K.A. reports salary and data collection for the manuscript supported by a grant received from the CDC Emerging Infections Program. N.B. reports an agreement to consult for the GSK. E.S. reports grant funding for the population-based Influenza Hospitalization Surveillance Project (IHSP) and COVID-Net activities, including support for personnel and equipment for data collection activities from the Council for State and Territorial Epidemiologists (CSTE). W.S. reports a grant from the CDC Emerging Infections Program. H.K.T. reports a grant from the CDC. A.G. reports a grant from the CSTE. All other authors report no potential conflicts.
Figures



Similar articles
-
Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults - Influenza Hospitalization Surveillance Network, United States, 2010-2023.MMWR Surveill Summ. 2024 Oct 31;73(6):1-18. doi: 10.15585/mmwr.ss7706a1. MMWR Surveill Summ. 2024. PMID: 39471107 Free PMC article.
-
Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010-19: a repeated cross-sectional study.Lancet Microbe. 2023 Nov;4(11):e903-e912. doi: 10.1016/S2666-5247(23)00187-8. Epub 2023 Sep 25. Lancet Microbe. 2023. PMID: 37769676 Free PMC article.
-
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.JAMA Netw Open. 2024 Apr 1;7(4):e244954. doi: 10.1001/jamanetworkopen.2024.4954. JAMA Netw Open. 2024. PMID: 38573635 Free PMC article.
-
Rates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes-Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2017.Open Forum Infect Dis. 2022 Mar 16;9(5):ofac131. doi: 10.1093/ofid/ofac131. eCollection 2022 May. Open Forum Infect Dis. 2022. PMID: 35450083 Free PMC article.
-
Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.JAMA Netw Open. 2021 Aug 2;4(8):e2121880. doi: 10.1001/jamanetworkopen.2021.21880. JAMA Netw Open. 2021. PMID: 34427679 Free PMC article.
Cited by
-
Analytical performance evaluation of a multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, influenza A/B, and RSV.PeerJ. 2025 Jul 30;13:e19693. doi: 10.7717/peerj.19693. eCollection 2025. PeerJ. 2025. PMID: 40755805 Free PMC article.
-
COVID-19 Vaccination Strategies in the Endemic Period: Lessons from Influenza.Vaccines (Basel). 2024 May 9;12(5):514. doi: 10.3390/vaccines12050514. Vaccines (Basel). 2024. PMID: 38793765 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention . Disease burden of flu. Available at: https://www.cdc.gov/flu/about/burden/index.html. Accessed March 23, 2023.
-
- Molinari NAM, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086–96. - PubMed